Ricardo Pérez-Fuentes

Dr. Ricardo Pérez-Fuentes


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
ANAdriana Nieva-Vazquez
Adriana Nieva-Vazquez
RPRicardo Pérez-Fuentes
Ricardo Pérez-Fuentes
ETEnrique Torres-Rasgado
Enrique Torres-Rasgado
JLJosé G. López-López
José G. López-López
JRJose R. Romero
Jose R. Romero
Background and Aims: Resistin is involved in the development of obesity and insulin resistance (IR) in mice and may play a similar role in humans through mechanisms that remain unresolved. The objective of this study was to characterize the relationship between resistin levels in obese subjects with and without IR among Hispanic subjects. Material and Methods: A cross-sectional study was performed on 117 nondiabetic Hispanic subjects of both genders that were allocated into three study groups: A control group ( n =47) of otherwise healthy individuals in metabolic balance, a group with obesity (OB) ( n =36), and a group with obesity and IR (OB-IR) ( n =34). Anthropometric and clinical characterization was carried out, and resistin levels were determined by enzyme-linked immunosorbent assay (ELISA). Results: We found that resistin levels were higher in OB and OB-IR groups when compared to the control group (1331.79±142.15 pg/mL, 1266.28±165.97 pg/mL vs. 959.21±171.43 pg/mL; P <0.05), an effect that was not confounded by age (control, 34.04±10.00 years; OB, 37.30±10.78 years; and OB-IR, 35.67±10.15 years). In addition, we observed a significant correlation ( P <0.001) between resistin levels and higher adiposity and insulin sensitivity (IS) in our cohort. Conclusions: Our results suggest that higher resistin levels are associated with higher adiposity and lower IS among obese Hispanic subjects.

1 July 2014 in Archives of Medical Research
Verified
Journal Article
Closed access
BBBlanca G. Baez-Duarte
Blanca G. Baez-Duarte
FMFrancisco Mendoza-Carrera
Francisco Mendoza-Carrera
AGAlejandra García-Zapién
Alejandra García-Zapién
SFSilvia E. Flores-Martínez
Silvia E. Flores-Martínez
JSJosé Sánchez-Corona
José Sánchez-Corona
RPRicardo Pérez-Fuentes
Ricardo Pérez-Fuentes

1 October 2002 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
MSMC Sánchez-Guillén
MC Sánchez-Guillén
CBChristian Barnabé
Christian Barnabé
JGJf Guégan
Jf Guégan
MTM Tibayrenc
M Tibayrenc
MVM Velásquez-Rojas
M Velásquez-Rojas
RPRicardo Pérez-Fuentes
Ricardo Pérez-Fuentes
Blood transfusion is the second most common transmission route of Chagas disease in many Latin American countries. In Mexico, the prevalence of Chagas disease and impact of transfusion of Trypanosoma cruzi-contaminated blood is not clear. We determined the seropositivity to T. cruzi in a representative random sample, of 2,140 blood donors (1,423 men and 647 women, aged 19-65 years), from a non-endemic state of almost 5 millions of inhabitants by the indirect hemagglutination (IHA) and enzyme linked immunosorbent assay (ELISA) tests using one autochthonous antigen from T. cruzi parasites, which were genetically characterized like TBAR/ME/1997/RyC-V1 (T. cruzi I) isolated from a Triatoma barberi specimen collected in the same locality. The seropositivity was up to 8.5% and 9% with IHA and ELISA tests, respectively, and up to 7.7% using both tests in common. We found high seroprevalence in a non-endemic area of Mexico, comparable to endemic countries where the disease occurs, e.g. Brazil (0.7%), Bolivia (13.7%) and Argentina (3.5%). The highest values observed in samples from urban areas, associated to continuous rural emigration and the absence of control in blood donors, suggest unsuspected high risk of transmission of T. cruzi, higher than those reported for infections by blood e.g. hepatitis (0.1%) and AIDS (0.1%) in the same region.

1 May 2016 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
MGM. Elba Gonzalez-Mejia
M. Elba Gonzalez-Mejia
LPLeonardo M. Porchia
Leonardo M. Porchia
ETEnrique Torres-Rasgado
Enrique Torres-Rasgado
GRGuadalupe Ruiz-Vivanco
Guadalupe Ruiz-Vivanco
PPPatricia Pulido-Pérez
Patricia Pulido-Pérez
RPRicardo Pérez-Fuentes
Ricardo Pérez-Fuentes
Background: Metabolic Syndrome (MetS) is associated with elevated risk for developing diabetes and cardiovascular disease. A key component of MetS is the development of insulin resistance (IR). The homeostatic model assessment (HOMA) model can determine IR by using insulin or C-peptide concentrations; however, the efficiency of insulin and C-peptide to determine MetS has not been compared. The aim of the study was to compare the efficiency of C-peptide and insulin to determine MetS in Mexicans. Methods: Anthropometrics, glucose, insulin, C-peptide, triglycerides, and high-density lipoproteins were determined in 156 nonpregnant females and 114 males. Subjects were separated into normal or positive for MetS. IR was determined by the HOMA2 calculator using insulin or C-peptide. Correlations were calculated using the Spearman correlation coefficient (ρ). Differences between correlations were determined by calculating Steiger's Z. The sensitivity was determined by the area under receiver operating characteristics curve (AUC) analysis. Results: : Independent of the MetS definition [Adult Treatment Panel III (ATP III), International Diabetes Federation (IDF), or World Health Organization (WHO)], C-peptide and insulin were significantly higher in MetS subjects ( P < 0.05). C-peptide and insulin correlated with all components of MetS; however, for waist circumference, waist-to-hip ratio, and fasting plasma glucose, C-peptide correlated better than insulin ( P < 0.05). Moreover, C-peptide (AUC = 0.72–0.78) was a better marker than insulin (AUC = 0.62–0.72) for MetS ( P < 0.05). Finally, HOMA2-IR calculated with C-peptide (AUC = 0.80–0.84) was more accurate than HOMA2-IR calculated with insulin (AUC = 0.68–0.75, P < 0.05) at determining MetS. Conclusion: C-peptide is a strong indicator of MetS. Since C-peptide has recently emerged as a biomolecule with significant importance for inflammatory diseases, monitoring C-peptide levels will aid clinicians in preventing MetS.

Verified
Journal Article
Open access
PDF file
MHMaría Elena Hernández Hernández
María Elena Hernández Hernández
EREnrique Torres rasgado
Enrique Torres rasgado
PPPatricia Pulido
Patricia Pulido
LNLeticia Nicolas-Toledo
Leticia Nicolas-Toledo
MMMargaríta Martínez-Gómez
Margaríta Martínez-Gómez
JRJosé Ricardo Romero
José Ricardo Romero
Oxidative stress plays an important role in vascular complications observed in patients with obesity and Type 2 Diabetes (T2D). Xanthine oxidase (XO) breaks down purine nucleotides into uric acid and contributes to the production of reactive oxygen species (ROS). However, the relationship between XO activity and glucose homeostasis in T2D subjects with obesity is unclear. We hypothesized that disordered glucose levels are associated with serum XO activity in overweight women and men with T2D and without hyperuricemia. We studied serum XO activity in women and men with and without T2D. Our results show that serum XO activity was greater in T2D patients with body mass index (BMI) ≥ 25 kg/m2 than in those with BMI < 25 kg/m2 (p < 0.0001). Sex-based comparative analyses of overweight T2D patients showed that serum XO activity correlated with homeostasis model assessment of β-cell function (HOMA-β), fasting plasma glucose (FPG), and hemoglobin A1C in overweight T2D women but not in overweight T2D men. In addition, as compared to overweight T2D men, women had higher high-sensitivity C-reactive protein (hs-CRP) levels. However, overweight T2D men had higher XO activity and uric acid levels than women. Our results suggest that XO activity is higher in overweight T2D patients, especially in men, but is more sensitive to disordered glucose levels in overweight women with T2D.

4 January 2021 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
RORenata Ochoa-Précoma
Renata Ochoa-Précoma
BPBlanca T. Pacheco-Soto
Blanca T. Pacheco-Soto
LPLeonardo M. Porchia
Leonardo M. Porchia
EREnrique Torres rasgado
Enrique Torres rasgado
RPRicardo Pérez-Fuentes
Ricardo Pérez-Fuentes
MGM. Elba Gonzalez-Mejia
M. Elba Gonzalez-Mejia